Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Antithrombotic Treatments After Aortic Valve Replacement. Rivaroxaban: A New Antithrombotic Treatment for Patients With Mechanical Prosthetic Aortic Heart Valve. (CATHAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02128841
Recruitment Status : Terminated (not enough patients)
First Posted : May 1, 2014
Last Update Posted : November 17, 2017
Sponsor:
Information provided by (Responsible Party):
University Hospital Inselspital, Berne